Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein

Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051

A68: a Major Subunit of Paired Helical Filaments and Derivatized Forms of Normal Tau

Lee, V. M.-Y., Balin, B. J., Otvos, L., & Trojanowski, J. Q. (1991) · Science · doi:10.1126/science.1899488 · Cited by 1,418

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

Goedert, M., Wischik, C. M., Crowther, R. A., Walker, J. E., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.11.4051 · Cited by 1,134

Tau proteins of alzheimer paired helical filaments: Abnormal phosphorylation of all six brain isoforms

Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122

Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease.

Wischik, C. M., Novak, M., Thøgersen, H. C., Edwards, P. C., Runswick, M. J., Jakes, R., Walker, J. E., Milstein, C., Roth, M., & Klug, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.12.4506 · Cited by 939

Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

Goedert, M., & Jakes, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07870.x · Cited by 929

Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding

Bramblett, G. T., Goedert, M., Jakes, R., Merrick, S. E., Trojanowski, J. Q., & Lee, V. M. Y. (1993) · Neuron · doi:10.1016/0896-6273(93)90057-x · Cited by 903

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

Braak, F., Braak, H., & Mandelkow, E. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 769

Tau protein and the neurofibrillary pathology of Alzheimer's disease

Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 721

Time-course remodeling and pathology intervention of α-synuclein amyloid fibril by heparin and heparin-like oligosaccharides

Tao, Y., Xu, P. H., Zhang, S., Shangguan, W., Yang, G., Liu, K., Li, X., Sun, Y., Zhao, Q., Li, D., et al. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01407-2 · Cited by 14

Oxidative Stress Conditions Result in Trapping of PHF-Core Tau (297–391) Intermediates

Maina, M. B., Al‐Hilaly, Y. K., Burra, G., Rickard, J. E., Harrington, C. R., Wischik, C. M., & Serpell, L. C. (2021) · Cells · doi:10.3390/cells10030703 · Cited by 14

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

Islam, M., Shen, F., Regmi, D., & Du, D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114979 · Cited by 14

Tau oligomers accumulation sensitizes prostate cancer cells to docetaxel treatment

Martellucci, S., Clementi, L., Sabetta, S., Muzi, P., Mattei, V., Bologna, M., & Angelucci, A. (2021) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-021-03598-3 · Cited by 15

Human apolipoprotein E accelerates microtubule polymerization in vitro

Scott, B. L., Welch, K., deSerrano, V. S., Moss, N. C., Roses, A. D., & Strittmatter, W. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00180-3 · Cited by 14

Relationship between microtubule-binding repeats and morphology of neurofibrillary tangle in Alzheimer's disease

Kitamura, T., Sugimori, K., Sudo, S., & Kobayashi, K. (2005) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2005.00488.x · Cited by 14

Specific proteoglycans as potential causative agents and relevant targets for therapeutic intervention in Alzheimer's disease and other amyloidosis

Snow, A. D., & Castillo, G. M. (1997) · Amyloid · doi:10.3109/13506129708995283 · Cited by 14

Modeling tauopathy: a range of complementary approaches

Hall, G. F., & Yao, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.002 · Cited by 14

Phosphorylated p38MAPK specific antibodies cross‐react with sarkosyl‐insoluble hyperphosphorylated tau proteins

Sahara, N., Vega, I. E., Ishizawa, T., Lewis, J., McGowan, E., Hutton, M., Dickson, D., & Yen, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02558.x · Cited by 15

HS3ST2 expression induces the cell autonomous aggregation of tau

Huynh, M. B., Rebergue, N., Merrick, H., Gómez-Henao, W., Jospin, E., Biard, D. S. F., & Papy-García, D. (2022) · Scientific Reports · doi:10.1038/s41598-022-13486-6 · Cited by 15

Phase separation of the microtubule-associated protein tau

Chakraborty, P., & Zweckstetter, M. (2022) · Essays in Biochemistry · doi:10.1042/ebc20220066 · Cited by 15

A flash in the pan: Dissecting dynamic amyloid intermediates using fluorescence

Nath, A., & Rhoades, E. R. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.02.044 · Cited by 13

In vitro comparison of major memory-support dietary supplements for their effectiveness in reduction/inhibition of beta-amyloid protein fibrils and tau protein tangles: key primary targets for memory loss

Snow, A. D., Cummings, J. A., Tanzi, R. E., & Lake, T. P. (2021) · Scientific Reports · doi:10.1038/s41598-020-79275-1 · Cited by 14

Prolonged nitric oxide treatment induces tau aggregation in SH-SY5Y cells

Takahashi, M., Chin, Y., Nonaka, T., Hasegawa, M., Watanabe, N., & Arai, T. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2011.12.067 · Cited by 13

An association study of a polymorphism in the heparan sulfate proteoglycan gene (perlecan, HSPG2) and Alzheimer's disease

Rosenmann, H., Meiner, Z., Kahana, E., Aladjem, Z., Friedman, G., Ben‐Yehuda, A., Grenader, T., Wertman, E., & Abramsky, O. (2004) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30015 · Cited by 13

Isothermal titration calorimetry and vesicle leakage assays highlight the differential behaviors of tau repeat segments upon interaction with anionic lipid membranes

Dicke, S. S., Tatge, L., Engen, P., Culp, M., & Masterson, L. R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.007 · Cited by 13

Our Working Point of View of Tau Protein

Ávila, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170600 · Cited by 14

Discovery of new lesions in neurodegenerative diseases with monoclonal antibody techniques: is there a non-amyloid precursor to senile plaques?

Dickson, D. W. (1997) · Europe PMC (PubMed Central) · Cited by 13

Trans-Channel Fluorescence Learning Improves High-Content Screening for Alzheimer's Disease Therapeutics

Wong, D. R., Conrad, J. C., Johnson, N. R., Ayers, J. I., Laeremans, A., Lee, J. C., Lee, J., Prusiner, S. B., Bandyopadhyay, S., Butte, A. J., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-022-00490-8 · Cited by 13

Assembled tau filaments differ from native paired helical filaments as determined by scanning transmission electron microscopy (STEM)

Ksiȩżak-Reding, H., Yang, G., Simon, M. N., & Wall, J. S. (1998) · Brain Research · doi:10.1016/s0006-8993(98)01052-x · Cited by 13

The Biochemistry of Alzheimer??s Disease

Stege, G. J. J., & Bosman, G. J. C. G. M. (1999) · Drugs & Aging · doi:10.2165/00002512-199914060-00004 · Cited by 13

Seed structure and phosphorylation in the fuzzy coat impact tau seeding competency

Kasen, A., Lövestam, S., Breton, E., Meyerdirk, L. K., McPhail, J. A., Piché, K., Louwrier, A., Capan, C. D., Lee, H., Scheres, S. H. W., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64312-2 · Cited by 17

Proteomic Analysis of Hydromethylthionine in the Line 66 Model of Frontotemporal Dementia Demonstrates Actions on Tau-Dependent and Tau-Independent Networks

Schwab, K., Melis, V., Harrington, C. R., Wischik, C. M., Magbagbeolu, M., Theuring, F., & Riedel, G. (2021) · Cells · doi:10.3390/cells10082162 · Cited by 11

Effects of Charged Polyelectrolytes on Amyloid Fibril Formation of a Tau Fragment

Islam, M., Argueta, E., Wojcikiewicz, E. P., & Du, D. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00374 · Cited by 12

Expanded Conformations of Monomeric Tau Initiate Its Amyloidogenesis**

Fernández‐Ramírez, M. D. C., Ng, K. K., Menéndez, M., Laurents, D. V., Hervás, R., & Carrión‐Vázquez, M. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202209252 · Cited by 12

Chemical Imaging of RNA‐Tau Amyloid Fibrils at the Nanoscale Using Tip‐Enhanced Raman Spectroscopy

Cooney, G. S., Talaga, D., Ury‐Thiery, V., Fichou, Y., Huang, Y., Lecomte, S., & Bonhommeau, S. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202314369 · Cited by 15

Unknown roles of tau pathology in neurological disorders. Challenges and new perspectives

Olesen, M. A., Villavicencio-Tejo, F., Cuevas-Espinoza, V., & Quintanilla, R. A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102594 · Cited by 12

Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases

Böken, D., Wu, Y., Zhang, Z.-W., & Klenerman, D. (2024) · ChemBioChem · doi:10.1002/cbic.202400877 · Cited by 11

Sensitive detection and propagation of brain-derived tau assemblies in HEK293-based wild-type tau seeding assays

Huang, M., & McEwan, W. A. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108245 · Cited by 12

Glycosaminoglycans in Neurodegenerative Diseases

Jin, W., Zhang, F., & Linhardt, R. J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-70115-4_9 · Cited by 13

Light Microscopy and Dynamic Light Scattering to Study Liquid-Liquid Phase Separation of Tau Proteins In Vitro

Hochmair, J., Exner, C., Betzel, C., Mandelkow�, E., & Wegmann, S. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2597-2_15 · Cited by 12

Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein

Kumar, H., & Udgaonkar, J. B. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.04.004 · Cited by 12

Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools

Landrieu, I., Dupré, E., Sinnaeve, D., Hajjar, L. E., & Smet‐Nocca, C. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.886382 · Cited by 12

Therapeutic Targets in Alzheimer's Disease and Related Tauopathies

Corbo, C. P., & Alonso, A. D. C. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385506-0.00002-8 · Cited by 13

Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy

Emmerson, J. T., Malcolm, J. C., Carmo, S. D., Nguyen, P., Breuillaud, L., Martínez-Trujillo, J., & Cuello, A. C. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106317 · Cited by 11

High-Throughput Single-Particle Characterization of Aggregation Pathways and the Effects of Inhibitors for Large (Megadalton) Protein Oligomers

Jordan, J. S., Harper, C. C., & Williams, E. R. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04669 · Cited by 11

Cellular Uptake of Tau Aggregates Triggers Disulfide Bond Formation in Four-Repeat Tau Monomers

Krzesinski, B. J., Holub, T. J., Gabani, Z. Y., & Margittai, M. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00607 · Cited by 11

Untangling the role of tau in Alzheimer’s disease: A unifying hypothesis

Bhatia, N. S., & Hall, G. F. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0114-5 · Cited by 11

Alternative splicing in aging and Alzheimer's disease: Highlighting the role of tau and estrogen receptor α isoforms in the hypothalamus

Ishunina, T. A. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00012-5 · Cited by 11

Magnetic Resonance Imaging in Tauopathy Animal Models

Ni, R. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.791679 · Cited by 11

Heparin-Assisted Amyloidogenesis Uncovered through Molecular Dynamics Simulations

Khurshid, B., Rehman, A. U., Luo, R., Khan, A., Wadood, A., & Anwar, J. (2022) · ACS Omega · doi:10.1021/acsomega.2c01034 · Cited by 11

PIP2 Phospholipid‐Induced Aggregation of Tau Filaments Probed by Tip‐Enhanced Raman Spectroscopy

Talaga, D., Smeralda, W., Lescos, L., Hunel, J., Lepejova-Caudy, N., Cullin, C., Bonhommeau, S., & Lecomte, S. (2018) · Angewandte Chemie · doi:10.1002/ange.201809636 · Cited by 11

Head-to-Head Comparison of Different Blood Collecting Tubes for Quantification of Alzheimer’s Disease Biomarkers in Plasma

Jiang, L., Ding, X., Wang, W., Yang, X., Li, T., & Lei, P. (2022) · Biomolecules · doi:10.3390/biom12091194 · Cited by 12

Dynamic-Inspired Perspective on the Molecular Inhibitor of Tau Aggregation by Glucose Gallates Based on Human Neurons

Hu, Y., Yang, D., Tu, Y., Chai, K., Chu, L., Shi, S., & Yao, T. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.1c00554 · Cited by 11

α-Synuclein Aggregation and Parkinson’s Disease

Uversky, V. N. (2007) · Springer eBooks · doi:10.1007/978-0-387-36534-3_4 · Cited by 11

Molecular genetics of familial parkinsonism

Wszołek, Z. K., & Markopoulou, K. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00030-9 · Cited by 11

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

Larner, A. J. (1999) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.9.10.1359 · Cited by 11

Towards a Mechanistic Model of Tau-Mediated Pathology in Tauopathies: What Can We Learn from Cell-Based In Vitro Assays?

Sala‐Jarque, J., Zimkowska, K., Ávila, J., Ferrer, I., & del Río, J. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911527 · Cited by 11

Quantitative Assays for Catalytic Photo-Oxygenation of Alzheimer Disease-Related Tau Proteins

Umeda, H., Sawazaki, T., Furuta, M., Suzuki, T., Kawashima, S. A., Mitsunuma, H., Hori, Y., Tomita, T., Sohma, Y., & Kanai, M. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00264 · Cited by 10

Chronic Formaldehyde-Mediated Impairments and Age-Related Dementia

Jun-Ye, M. I. A. O., & He, R. (2012) · InTech eBooks · doi:10.5772/34949 · Cited by 10

A Computational Approach for Identifying the Chemical Factors Involved in the Glycosaminoglycans-Mediated Acceleration of Amyloid Fibril Formation

Monsellier, É., Ramazzotti, M., Taddei, N., & Chiti, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011363 · Cited by 10

Structural mapping techniques distinguish the surfaces of fibrillar 1N3R and 1N4R human tau

Caroux, E., Redeker, V., Madiona, K., & Melki, R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101252 · Cited by 9

Pyrroloquinoline Quinone Regulates Enteric Neurochemical Plasticity of Weaned Rats Challenged With Lipopolysaccharide

Shi, C., Xu, S., Huang, C., Wang, Z., Wang, W., Ming, D., Yin, X., Liu, H., & Wang, F. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.878541 · Cited by 10

Effect of DNA on Filament Formation of Tau Microtubule-Binding Domain: Structural Dependence of DNA

Hikosou, R., Kurabayashi, Y., Doumoto, M., Hoshitoku, K., Mizushima, F., Minoura, K., Tomoo, K., & Ishida, T. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.1030 · Cited by 10

Mechanisms of tauopathies

Froelich-Fabre, S., & Bhat, R. V. (2004) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2004.11.012 · Cited by 10

Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filamentsPreprint

Lövestam, S., Wagstaff, J. L., Katsinelos, T., Freund, S. M. V., Goedert, M., & Scheres, S. H. W. (2025) · eLife · doi:10.7554/elife.104778.1 · Cited by 10

An amphiphilic material arginine–arginine–bile acid promotes α-synuclein amyloid formation

Lin, Y., Park, S.-H., Bok, E., Heo, Y., Yang, S.-B., Yi, Y.-S., Lee, J.-H., Seo, D., Jo, E., Lim, S., et al. (2023) · Nanoscale · doi:10.1039/d3nr01468a · Cited by 9

Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers

Tan, W., Thiruppathi, J., Hong, S. H., Puth, S., Pheng, S., Mun, B.-R., Choi, W., Lee, K., Park, H., Nguyen, D. T., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-00904-1 · Cited by 10

dGAE(297–391) Tau Fragment Promotes Formation of Chronic Traumatic Encephalopathy‐Like Tau Filaments

Kitoka, K., Lends, A., Kučinskas, G., Bula, A. L., Krasauskas, L., Smirnovas, V., Žilková, M., Kováčech, B., Škrabana, R., Hritz, J., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202407821 · Cited by 10

Direct Observation of the Self‐Aggregation of R3R4 Bi‐repeat of Tau Protein

Jayan, P., Vahid, A. A., Kizhakkeduth, S. T., Muhammed, S. O. H., Shibina, A. B., & Vijayan, V. (2021) · ChemBioChem · doi:10.1002/cbic.202100013 · Cited by 8

Effect of Natural Osmolytes on Recombinant Tau Monomer: Propensity of Oligomerization and Aggregation

Arar, S. H., Haque, M. A., Bhatt, N. N., Zhao, Y., & Kayed, R. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00614 · Cited by 9

Role of p73 in Alzheimer disease: lack of association in mouse models or in human cohorts

Vardarajan, B. N., Vergote, D., Tissir, F., Logue, M. W., Yang, J., Daude, N., Ando, K., Rogaeva, E. A., Lee, J. J., Cheng, R., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-10 · Cited by 9

Preparation of Tau Oligomers After the Protein Extraction from Bacteria and Brain Cortices

Argyrousi, E. K., Staniszewski, A., Nicholls, R. E., & Arancio, O. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7816-8_7 · Cited by 9

Glycosaminoglycan Analysis in Brain Stems from Animals Infected with the Bovine Spongiform Encephalopathy Agent

Papakonstantinou, E., Karakiulakis, G., Roth, M., Verghese-Nikolakaki, S., Dawson, M., Papadopoulos, O., & Sklaviadis, T. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1405 · Cited by 9

Cytotoxic Helix-Rich Oligomer Formation by Melittin and Pancreatic Polypeptide

Singh, P. K., Ghosh, D., Tewari, D., Mohite, G. M., Carvalho, E. J., Jha, N. N., Jacob, R. S., Sahay, S., Banerjee, R., Bera, A. K., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120346 · Cited by 9

Phosphorylation and Acetylation of Proteins as Posttranslational Modification: Implications in Human Health and Associated Diseases

Qausain, S., Hemalatha, S., Jamal, S., Nasiruddin, M., & Khan, M. K. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00003-5 · Cited by 9

Apolipoprotein E4 stimulates sulfation of glycosaminoglycans in neural cells

Bonay, P., & Ávila, J. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00096-x · Cited by 9

Evidence for independent mechanisms and a multiple-hit model of tau assembly

Deture, M. A., Granger, B., Grover, A., Hutton, M., & Yen, S.-H. C. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.087 · Cited by 9

Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filamentsPreprint

Lövestam, S., Wagstaff, J. L., Katsinelos, T., Shi, J., Freund, S. M. V., Goedert, M., & Scheres, S. H. W. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.23.619846 · Cited by 9

Short-chain polyphosphates induce tau fibrillation and neurotoxicity in human iPSC-derived retinal neurons

(2025) · doi:10.1038/s41419-025-07662-5 · Cited by 8

Heterogeneous Dynamics of the Fuzzy Coat of Full-Length Phospho-Mimetic Tau Fibrils

Zhang, J. Y., Dregni, A. J., & Hong, M. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.5c18540 · Cited by 8

Endogenous and Exogenous Factors in Hyperphosphorylation of Tau in Alzheimer′s Disease*

Wei, Y., Jun-Ye, M. I. A. O., & Liu, Y. M. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00365 · Cited by 8

The Adult Neurogenesis Theory of Alzheimer’s Disease

Abbate, C. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-221279 · Cited by 11

The Role of Aβ and Tau Oligomers in the Pathogenesis of Alzheimer’s Disease

Bhaskar, K., & Lamb, B. T. (2011) · Springer eBooks · doi:10.1007/978-94-007-2774-8_5 · Cited by 8

Tau seeding activity in various regions of down syndrome brain assessed by two novel assays

Jin, N., Gu, J., Wu, R., Chu, D., Tung, Y. C., Węgiel, J., Wısnıewskı, T., Gong, C., Iqbal, K., & Liu, F. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01436-2 · Cited by 8

Effect of sucrose on BSA denatured aggregation at high concentration studied by the iso-conversional method and the master plots method

Cao, X., Wang, Z., Yang, X. N., Liu, Y., & Wang, C. (2009) · Journal of Thermal Analysis and Calorimetry · doi:10.1007/s10973-008-9307-5 · Cited by 8

Inferring Mechanistic Parameters from Amyloid Formation Kinetics by Approximate Bayesian Computation

Nakatani-Webster, E., & Nath, A. (2017) · Biophysical Journal · doi:10.1016/j.bpj.2017.01.011 · Cited by 8

Tauopathies and α-Synucleinopathies

Goedert, M., & Spillantini, M. G. (2000) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04056-0_6 · Cited by 8

Familial Amyotrophic Lateral Sclerosis and Alzheimer’s Disease

Wong, P. C., Borchelt, D., Lee, M. K., Pardo, C. A., Thinakaran, G., Martin, L. J., Sisodia, S. S., & Price, D. L. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4869-0_9 · Cited by 8

Site-Specific C-Terminal Fluorescent Labeling of Tau Protein

Bryan, L. C., Awasthi, S., Li, Y., Nirmalraj, P. N., Balog, S., Yang, J., & Mayer, M. (2022) · ACS Omega · doi:10.1021/acsomega.2c06139 · Cited by 7

Tau Fibrillation Induced by Heparin or a Lysophospholipid Show Different Initial Oligomer Formation

Rasmussen, H. Ø., Nielsen, J., de Poli, A., Otzen, D. E., & Pedersen, J. S. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168194 · Cited by 7

Glycosaminoglycans enhance the fibrillation propensity of the β2-microglobulin cleavage variant – ΔK58-β2m

Corlin, D. B., Johnsen, C. K., Nissen, M. H., & Heegaard, N. H. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.10.008 · Cited by 7

Characterization of Alzheimer paired helical filaments by electron microscopy

Hernández, F., Engel, T., Gómez‐Ramos, A., Pérez, M., & Ávila, J. (2005) · Microscopy Research and Technique · doi:10.1002/jemt.20194 · Cited by 7

Role of Phosphorylation and Hyperphosphorylation of Tau in Its Interaction with βα Dimeric Tubulin Studied from a Bioinformatics Perspective

Dixit, H., Selvaa Kumar, C., Chaudhary, R., Thaker, D., Gadewal, N. S., & Dasgupta, D. (2020) · Avicenna Journal of Medical Biotechnology · doi:10.18502/ajmb.v13i1.4579 · Cited by 7

Alternative Splicing of Amino-Terminal Tau mRNA in Rat Spinal Cord during Development and Following Axonal Injury

Halverson, R. A., Chambers, C. B., & Muma, N. A. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7637 · Cited by 7

Twelve phosphomimetic mutations induce the assembly of recombinant full-length human tau into paired helical filamentsPreprint

Lövestam, S., Wagstaff, J. L., Katsinelos, T., Shi, J., Freund, S. M. V., Goedert, M., & Scheres, S. H. W. (2025) · eLife · doi:10.7554/elife.104778 · Cited by 7

The PET tracer [ 11 C]MODAG-005 targets alpha-synuclein aggregates in the brain

Saw, R. S., Haas, S., Schmidt, F., Ryazanov, S., Leonov, A., Bleher, D., Grotegerd, A.-K., Kuebler, L., Röeben, B., Schmidt, F. P., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aec0813 · Cited by 6

Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation In Vitro

Cuadros, R., Pérez, M., Ruiz-Gabarre, D., Hernández, F., García‐Escudero, V., & Ávila, J. (2022) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00188 · Cited by 6

The induction of tau aggregation is restricted by sulfamethoxazole and provides new information regarding the use of the drug

Akbari, V., Bahramikia, S., Jalalvand, A. R., Mehrabi, M., Ezati, M., & Khodarahmi‬, R. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2273433 · Cited by 6

Travels with tau prions

Diamond, M. I. (2023) · Cytoskeleton · doi:10.1002/cm.21806 · Cited by 5

Severe neurodegeneration in brains of transgenic rats producing human tau prions

Ayers, J. I., Lopez, T. P., Steele, I. T., Oehler, A., Roman-Albarran, R., Cleveland, E., Chong, A., Carlson, G. A., Condello, C., & Prusiner, S. B. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02771-5 · Cited by 7

Drug Discovery and Screening Tool Development for Tauopathies by Focusing on Pathogenic Tau Repeat 3 Oligomers

Yoon, S., Kim, H. Y., Park, S., Cha, M., Kim, K., Lee, S., Kim, J., Bhang, S., & Kim, Y. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202411942 · Cited by 6

The Biology and Pathobiology of Tau Protein

Hall, G. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-788-0_15 · Cited by 6

The role of membranes in function and dysfunction of intrinsically disordered amyloidogenic proteins

Pathak, B. K., Dey, S., Mozumder, S., & Sengupta, J. (2022) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.08.001 · Cited by 6

Modulation of Primary and Secondary Processes in Tau Fibril Formation by Salt-Induced Dynamics

Vahid, A. A., Hassan, M. S. O., Sahayaraj, A. E., Babu, A. T., Kizhakkeduth, S. T., & Vijayan, V. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00852 · Cited by 6

Les protéoglycanes. (II) Rôles en pathologie.

Praillet, C., Grimaud, J.-A., & Lortat‐Jacob, H. (1998) · médecine/sciences · doi:10.4267/10608/1057 · Cited by 6

Glycosaminoglycans and Fibrillar Polymorphism

Malmos, K. G., & Otzen, D. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00026-2 · Cited by 6

Interaction of polymers with amyloidogenic peptides

Abraham, J. N., & Nardin, C. (2017) · Polymer International · doi:10.1002/pi.5483 · Cited by 6

Effect of cellular polyanion mimetics on tau peptide aggregation

Ismail, T., & Kanapathipillai, M. (2018) · Journal of Peptide Science · doi:10.1002/psc.3125 · Cited by 6

Sensory Neurons from Tau Transgenic Mice and Their Utility in Drug Screening

Tolkovsky, A. M., & Brelstaff, J. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7571-6_7 · Cited by 6

Alzheimer-like Changes in Microtubule-associated Protein Tau Induced by Sulfated Glycosaminoglycans

Hasegawa, M., Crowther, R. A., Jakes, R., & Goedert, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.52.33118 · Cited by 207

Alzheimer’s disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules

Alonso, A. D. C., Grundke-Iqbal, I., & Iqbal, K. (1996) · Nature Medicine · doi:10.1038/nm0796-783 · Cited by 859

Assembly of Alzheimer‐like filaments from full‐length tau protein

Crowther, R. A., Olesen, O. F., Smith, M. J., Jakes, R., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80260-2 · Cited by 154

Heparin-induced Conformational Change in Microtubule-associated Protein Tau as Detected by Chemical Cross-linking and Phosphopeptide Mapping

Paudel, H. K., & Li, W. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8029 · Cited by 89

Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs

Hernández, F., Pérez, M., Lucas, J. J., & Ávila, J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02455-1 · Cited by 25